Evidence map›Paper›PMID 31360205›Full record

ArticleArchives of medical science : AMS2019

Etanercept protects ovarian reserve against ischemia/reperfusion injury in a rat model.

Meryem Kurek Eken, Gulcin Sahin Ersoy, Ecmel Işık Kaygusuz, Belgin Devranoğlu, Mümtaz Takır, Özlem Tuğçe Çilingir, Özge Çevik

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Toxicological Assessment ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. New Potential Agent in Ovarian Ischemia Reperfusion Injury: Alpha Pinene.Journal of biochemical and molecular toxicology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Meryem Kurek EkenObstetrics and Gynecology Department, Medical Faculty, Adnan Menderes University, Aydın, Turkey.
Gulcin Sahin ErsoyObstetric and Gynecology Department, Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul, Turkey.
Ecmel Işık KaygusuzPathology Department, Zeynep Kamil Training and Research Hospital, Istanbul, Turkey.
Belgin DevranoğluInfertility Department, Zeynep Kamil Training and Research Hospital, Istanbul, Turkey.
Mümtaz TakırInternal Medicine Department, Division of Endocrinology and Metabolism, Istanbul Medeniyet University, Istanbul, Turkey.
Özlem Tuğçe ÇilingirDepartment of Histology and Embryology, School of Medicine, Marmara University, Istanbul, Turkey.
Özge ÇevikDepartment of Biochemistry, Medical Faculty, Adnan Menderes University, Aydın, Turkey.
Adnan Menderes University · TRZeynep Kamil Hospital · TRDr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi · TRIstanbul Medeniyet University · TRMarmara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEtanercept has been widely used in autoimmune diseases for blocking tumor necrosis factor α (TNF-α), which is an inflammatory cytokine. The anti-apoptotic and anti-inflammatory effects of etanercept against ischemia/reperfusion (I/R) injury have been shown for several tissues in rat studies, but to the best of our knowledge, there are no reports on its protective effects following similar injury in ovarian tissue. The aim of this study was to investigate whether etanercept has beneficial effects on ovarian I/R injury, as well as on ovarian reserve. MATERIAL AND

methodsTwenty-four rats were randomly divided into four groups (

resultsTissue GSH and SOD levels were significantly higher, while MDA and MPO levels were significantly lower in the I/R + etanercept group than in the I/R group (

conclusionsEtanercept attenuated inflammation and related oxidative stress and also helped to preserve ovarian reserve following ovarian I/R damage.

Indexed as

apoptosisetanerceptinflammationischemia/reperfusion injuryovaryoxidative injury

Identifiers

PMID31360205
PMCPMC6657239
OpenAlexW2915886905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.